Goltzman, David

An atlas of genetic influences on osteoporosis in humans and mice

23andMe Research Team, Morris, J. A., Kemp, J. P., Youlten, S. E., Laurent, L., Logan, J. G., Chai, R. C., Vulpescu, N. A., Forgetta, V., Kleinman, A., et al. (2019) · Nature Genetics

Bone health and osteoporosis researchGenetic Associations and Epidemiology

Cited by 773

A meta-analysis of the association of fracture risk and body mass index in women

Johansson, H., Kanis, J. A., Odén, A., McCloskey, E., Chapurlat, R. D., Christiansen, C., Cummings, S. R., Diez-Perez, A., Eisman, J. A., Fujiwara, S., et al. (2014) · Journal of Bone and Mineral Research

Bone health and osteoporosis researchMenopause: Health Impacts and Treatments

Cited by 480

Transgenic Mice Overexpressing Human Fibroblast Growth Factor 23 (R176Q) Delineate a Putative Role for Parathyroid Hormone in Renal Phosphate Wasting Disorders

Bai, X., Miao, D., Li, J., Goltzman, D., & Karaplis, A. C. (2004) · Endocrinology

Parathyroid Disorders and TreatmentsAlkaline Phosphatase Research Studies

Cited by 329

Expression of Concern: Up‐regulation of Wnt‐1 and β‐catenin production in patients with advanced metastatic prostate carcinoma

Chen, G., Shukeir, N., Potti, A., Sircar, K., Aprikian, A., Goltzman, D., & Rabbani, S. A. (2004) · Cancer

Wnt/β-catenin signaling in development and cancerProstate Cancer Treatment and Research

Cited by 283

Benefits and safety of dietary protein for bone health—an expert consensus paper endorsed by the European Society for Clinical and Economical Aspects of Osteopororosis, Osteoarthritis, and Musculoskeletal Diseases and by the International Osteoporosis Foundation

Rizzoli, R., Biver, E., Bonjour, J.-P., Coxam, V., Goltzman, D., Kanis, J. A., Lappe, J., Rejnmark, L., Sahni, S., Weaver, C., et al. (2018) · Osteoporosis International

Bone health and osteoporosis researchNutrition and Health in Aging

Cited by 164

Interactions between calcium and phosphorus in the regulation of the production of fibroblast growth factor 23 in vivo

Quinn, S. J., Thomsen, A. R. B., Pang, J. L., Kantham, L., Bräuner-Osborne, H., Pollak, M., Goltzman, D., & Brown, E. M. (2013) · American Journal of Physiology-Endocrinology and Metabolism

Parathyroid Disorders and TreatmentsAlkaline Phosphatase Research Studies

Cited by 115

Co-treatment of PTH with osteoprotegerin or alendronate increases its anabolic effect on the skeleton of oophorectomized mice.

Samadfam, R., Xia, Q., & Goltzman, D. (2007) · Journal of Bone and Mineral Research

Bone health and osteoporosis researchBone Metabolism and Diseases

Cited by 80

Inhibition of Nrf2 degradation alleviates age-related osteoporosis induced by 1,25-Dihydroxyvitamin D deficiency

Yang, R., Zhang, J., Li, J., Qin, R., Chen, J., Wang, R., Goltzman, D., & Miao, D. (2022) · Free Radical Biology and Medicine

Bone Metabolism and DiseasesGenomics, phytochemicals, and oxidative stress

Cited by 67

17β-estradiol plays the anti-osteoporosis role via a novel ESR1-Keap1-Nrf2 axis-mediated stress response activation and Tmem119 upregulation

Yang, R., Li, J., Zhang, J., Xue, Q., Qin, R., Wang, R., Goltzman, D., & Miao, D. (2023) · Free Radical Biology and Medicine

Bone Metabolism and DiseasesGenomics, phytochemicals, and oxidative stress

Cited by 48